CTOs on the Move

Attralus

www.attralus.com

 
Amyloid diseases are a diverse group of disorders, characterized by the deposition of amyloid protein fibrils in vital organs and tissues. There are approximately 30 different types of amyloidosis, each resulting from the misfolding and aggregation of a specific protein, and they are all severely debilitating, progressive, and often fatal.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.attralus.com
  • ‍329 Oyster Point Blvd Third Floor
    South San Francisco, BC USA 94080
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Attralus raised $25M on 09/14/2020

Similar Companies

OPK Biotech

OPK Biotech is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Selexys Pharmaceuticals

Selexys Pharmaceuticals is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ribometrix

Ribometrix is a platform therapeutics company discovering small molecule drugs that target functional 3D RNA structures to treat human diseases.

Process Environments

Process Environments is a League City, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Blaze Bioscience

Blaze Bioscience, Inc. is a privately held biotechnology company focused on guided therapies. Blaze was founded in 2010 by Dr. Jim Olson, a pediatric neuro-oncologist at the Fred Hutchinson Cancer Research Center and Seattle Children`s Hospital, and Heather Franklin, a former senior business executive from ZymoGenetics. Blaze is working to develop Tumor Paint products and Optide*-based guided therapeutics.